Compass Therapeutics
CMPX
#9355
Rank
NZ$0.26 B
Marketcap
NZ$1.48
Share price
10.29%
Change (1 day)
-80.48%
Change (1 year)

Earnings for Compass Therapeutics (CMPX)

Earnings in 2026 (TTM): -NZ$0.15 Billion

According to Compass Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.13 Billion a decrease over its 2024 earnings that were of -NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Compass Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.15 Billion9.23%
2025 -NZ$0.13 Billion28.63%
2024 -NZ$0.11 Billion12.43%
2023 -NZ$89.36 Million24.79%
2022 -NZ$71.61 Million-50.67%
2021 -NZ$0.15 Billion186.46%
2020 -NZ$50.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.28 Billion 92.56%๐Ÿ‡บ๐Ÿ‡ธ USA